VAIA
TECH icon

Virtus Alternative Investment Advisers’s Bio-Techne TECH Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-92
Closed -$7K – 199
2020
Q4 		$7K Sell
92
-88
-49% -$6.37K 0.1% 145
2020
Q3 		$11K Sell
180
-68
-27% -$4.42K 0.2% 207
2020
Q2 		$16K Sell
248
-232
-48% -$13.9K 0.25% 113
2020
Q1 		$23K Buy
480
+316
+193% +$15.8K 0.32% 74
2019
Q4 		$9K Buy
+164
New +$8.6K 0.14% 185

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Virtus Alternative Investment Advisers's TECH Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Bio-Techne (TECH) in Q1 2021, closing a stake of 92 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in TECH in Q4 2019 and held it in 5 quarters. The position peaked at $23K in Q1 2020. 470 funds tracked by Wall St. Rank hold TECH as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Bio-Techne position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 92 Bio-Techne shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in Bio-Techne in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's Bio-Techne position peaked at $23K in Q1 2020.
  • 470 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.